1)和田誠基,他:続発性骨粗鬆症―現状と問題点.骨粗鬆症治療 4:106-110,2005
2)Oefelein MG, et al:Skeletal fracture associated with androgen suppression induced osteoporosis;The clinical incidence and risk factors for patients with prostate cancer. J Urol 166:1724-1728, 2001
3)Nawata H, et al:The subcommittee to study diagnostic criteria for glucocorticoid-induced osteoporosis;Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23:105-109, 2005
4)安田重光,他:バセドウ病でみられる骨量減少の可逆性と不可逆性に関する検討.Osteoporosis Jpn 12:425-427,2004
5)Bilezikian JP, et al:Summary statement from a workshop on asymptomatic primary hyperparathyroidism;A perspective for the 21st century. J Bone Miner Res 17 (Suppl 2):N2-11, 2002
6)和田誠基,他:続発性骨粗鬆症としての観点からみた原発性副甲状腺機能亢進症治療基準の検討.Osteoporos Jpn 12:419-421,2004